Form 4: IQVIA EVP Sherbet Vests Performance RSUs

IQVIA Holdings Inc. Executive Vice President Eric Sherbet acquired 6,806 shares of common stock through performance-based restricted stock units, subsequently disposing of 1,915 shares for tax purposes.

Summary

• Eric Sherbet, Executive Vice President and General Counsel of IQVIA Holdings Inc., acquired 6,806 shares of common stock.
• These shares were acquired on February 8, 2026, upon the achievement of performance criteria for restricted stock units granted on February 13, 2023.
• The performance conditions were determined to be satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026.
• Following this acquisition, Sherbet beneficially owned 27,914 shares directly.
• Concurrently, Sherbet disposed of 1,915 shares of common stock at a price of $187.49 per share.
• This disposition is typically for tax withholding related to the vesting of the restricted stock units.
• After both transactions, Sherbet's direct beneficial ownership stands at 25,999 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as the vesting of performance-based RSUs indicates the company met its internal performance targets, reflecting positively on management's execution.

Positives

• The vesting of 6,806 performance-based restricted stock units indicates that the company's leadership achieved specific performance criteria, suggesting strong operational or financial results over the vesting period.
• The acquisition of shares by an executive aligns their interests with those of shareholders.

Negatives

• The disposition of 1,915 shares, while common for tax withholding, represents a reduction in the executive's direct ownership, albeit a small percentage of the total vested shares.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to RSU vesting, are common across the pharmaceutical and healthcare technology sectors, reflecting standard executive compensation practices tied to performance. The vesting indicates internal performance targets were met, which is generally a positive signal for the company's operational execution within its industry.

Comparison to Industry Standards

• This type of RSU vesting and subsequent tax-related disposition is a standard practice in executive compensation across major U.S. public companies, including peers in the healthcare information and clinical research industry such as Veeva Systems (VEEV) or Medidata Solutions (acquired by Dassault Systèmes).
• The vesting of performance-based units suggests IQVIA's internal performance metrics, which often include revenue growth, profitability, or specific project milestones, were achieved, aligning with best practices for incentivizing executive performance.

Stakeholder Impact

• Shareholders: The vesting of performance-based units suggests the company achieved its internal goals, which could be viewed positively by shareholders as it implies strong operational performance. The executive's continued significant ownership aligns interests.
• Employees: The successful vesting of executive compensation tied to performance may signal a healthy company performance environment.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the vesting of performance-based restricted stock units and a subsequent tax-related disposition. While the vesting indicates the company met its internal performance targets, which is a positive signal, the transaction itself is not a discretionary open-market purchase or sale that would significantly alter the investment thesis for IQVIA. It provides no new material information to warrant a change from a 'hold' position, assuming the investor's existing thesis remains intact.

Keywords

IQVIA Holdings, IQV, Eric Sherbet, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership